Companies /Basic Materials
Nutrien Ltd
NYSE: NTR Agricultural Inputs
$65.92
▼ $3.30 (−4.77%) today
Markets closed · 1:34am ET

Nutrien (NTR) Earnings History & Trends

EPS and revenue vs. Street estimates · SEC filings
NTR vs Market · 30-day return after each reportNTRS&P 500
0%+7%+14%+21%+1.3%+2.9%Q2 25+5.5%+1.9%Q3 25+1.5%−4.3%Q4 25−3.0%+0.8%Q1 26+20.9%−0.3%Q2 26
0%+7%+14%+21%Q2 25Q3 25Q4 25Q1 26Q2 26
NTR EPS Trend · estimate vs actualEstimateActual
$0.00$0.80$1.60$2.40$2.42$2.65Q2 25$0.97$0.97Q3 25$0.91$1.18Q4 25$0.54$0.51Q1 26$2.72$2.61Q2 26$0.77$0.61Q3 26
$0.00$0.80$1.60$2.40Q2 25Q4 25Q2 26
NTR Revenue Trend · estimate vs actualEstimateActual
$0$3.0B$6.0B$9.0B$10.4B$10.4BQ2 25$5.6B$6.0BQ3 25$5.3B$5.3BQ4 25$5.3B$6.0BQ1 26$10.4B$10.8BQ2 26$5.7B$6.1BQ3 26
$0$3.0B$6.0B$9.0BQ2 25Q4 25Q2 26

How Often Does Nutrien Beat Earnings Estimates?

Nutrien beat EPS estimates in 3 of its last 6 reported quarters, and has missed 3 quarters in a row.

NTR quarterly earnings per share and revenue versus Street estimates
Quarter EPS · est. Surprise Revenue · est. Surprise
Q3 2026 Adjusted EPS of $0.61 compares with GAAP diluted EPS of $0.60; adjusted net earnings were $290 million vs GAAP $284 million. Pre-tax adjustments: - $75 million share-based compensation expense - $5 million foreign exchange loss - $(42) million ARO/ERL related income for non-operating sites - $(29) million restructuring recovery Other items: - Q3 included $23 million of Trinidad-related expenses. - Q3 effective tax rate was 40%. - Q4 2026 is expected to include impairments tied to the White Springs and Trinidad shutdowns. $0.61 est. $0.77 −21.13% $6.1B est. $5.7B +7.02%
Q2 2026 Includes $66 million pre-tax restructuring costs ($52 million post-tax, $0.11 per diluted share) related to portfolio optimization initiatives $2.61 est. $2.72 −4.15% $10.8B est. $10.4B +3.92%
Q1 2026 $0.51 est. $0.54 −5.38% $6.0B est. $5.3B +14.39%
Q4 2025 $1.18 est. $0.91 +30.01% $5.3B est. $5.3B +0.63%
Q3 2025 $0.97 est. $0.97 +0.09% $6.0B est. $5.6B +7.24%
Q2 2025 $2.65 est. $2.42 +9.66% $10.4B est. $10.4B −0.09%

Figures from SEC filings and company reports. Not investment advice.